Summary
Background Sun protection factor (SPF) is assessed with sunscreen applied at 2 mg cm
À2
. People typically apply around 0Á8 mg cm À2 and use sunscreen daily for holidays. Such use results in erythema, which is a risk factor for skin cancer.
Objectives To determine (i) whether typical sunscreen use resulted in erythema, epidermal DNA damage and photoimmunosuppression during a sunny holiday, (ii) whether optimal sunscreen use inhibited erythema and (iii) whether erythema is a biomarker for photoimmunosuppression in a laboratory study.
Methods Holidaymakers (n = 22) spent a week in Tenerife (very high ultraviolet index) using their own sunscreens without instruction (typical sunscreen use). Others (n = 40) were given SPF 15 sunscreens with instructions on how to achieve the labelled SPF (sunscreen intervention). Personal ultraviolet radiation (UVR) exposure was monitored electronically as the standard erythemal dose (SED) and erythema was quantified. Epidermal cyclobutane pyrimidine dimers (CPDs) were determined by immunostaining, and immunosuppression was assessed by contact hypersensitivity (CHS) response.
Results There was no difference between personal UVR exposure in the typical sunscreen use and sunscreen intervention groups (P = 0Á08). The former had daily erythema on five UVR-exposed body sites, increased CPDs (P < 0Á001) and complete CHS suppression (20 of 22) . In comparison, erythema was virtually absent (P < 0Á001) when sunscreens were used at ≥ 2 mg cm À2 . A laboratory study showed that 3 SED from three very different spectra suppressed CHS by around~50%.
Conclusions Optimal sunscreen use prevents erythema during a sunny holiday. Erythema predicts suppression of CHS (implying a shared action spectrum). Given that erythema and CPDs share action spectra, the data strongly suggest that optimal sunscreen use will also reduce CPD formation and UVR-induced immunosuppression.
• Suboptimal sunscreen application is often associated with sunburn, which is a risk factor for skin cancer.
• Erythema is a biomarker of cyclobutane pyrimidine dimers (CPDs), which may initiate skin cancer.
• The suppression of the sensitization phase of the contact hypersensitivity (CHS) response is a model for photoimmunological events in skin cancer.
What does this study add?
• Typical sunscreen use during a week's holiday in Tenerife, with a very high UV index, resulted in erythema, epidermal CPD formation and almost complete suppression of CHS.
• There was no erythema, on five exposed body sites, when sunscreen (SPF 15) was applied three times daily at ≥ 2 mg cm À2 .
• Erythema is predictive of immunosuppression, irrespectively of the ultraviolet radiation (UVR) emission spectrum.
What is the translational message?
• People can learn to use sunscreens correctly to achieve the labelled SPF.
• The laboratory study demonstrated that erythema is a clinical and spectral biomarker for UVR-induced suppression of CHS.
• Prevention of holiday erythema is likely to reduce CPDs and photoimmunosuppression, which are critical risk factors for skin cancer.
• Avoidance of erythema is therefore a very important public health strategy.
Skin cancer incidence is increasing in many white-skinned populations. 1,2 Risk factors for malignant melanoma, basal cell carcinoma and squamous cell carcinoma (SCC) include sunburn (erythema), 3, 4 and SCC is also associated with low-level chronic suberythemal exposure. 5, 6 Solar ultraviolet radiation (UVR,~295-400 nm) induces DNA damage, especially cyclobutane pyrimidine dimers (CPDs), which may initiate mutations associated with basal cell carcinoma, actinic keratosis, SCC 7, 8 and melanoma. The action spectra (~295-360 nm) for human erythema and epidermal CPD induction are similar. 10 This suggests that DNA is a chromophore for erythema, which can be seen as a spectral clinical surrogate, or biomarker, for CPD. The UVRinduced suppression of acquired cutaneous immunity plays a role in skin cancer. 11 There are human action spectra for the suppression of the elicitation phase of recall immunity, [12] [13] [14] but not for the suppression of acquired immunity (i.e. sensitization phase), for which murine action spectroscopy identified trans-urocanic acid as a chromophore. 15 However, DNA has also been proposed as a chromophore based on mouse 16 and human 17 studies. The UVR-induced suppression of the sensitization phase of the contact hypersensitivity (CHS) response has been used as a model for the photoimmunological events in skin cancer.
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Sunscreen use is widely advocated to inhibit actinic keratosis (a biomarker for SCC) [19] [20] [21] and SCC, 22 with recent data to suggest that this may also be true for melanoma. 23, 24 The sun protection factor (SPF) of a sunscreen measures its ability to prevent erythema 24 h after a single exposure to solar simulated radiation (SSR). This index is determined with an application density of 2 mg cm À2 , but users typically apply much less, with a commensurate reduction in SPF. [25] [26] [27] [28] This may
give a false sense of security because sunscreens can be used to prolong solar exposure time 29, 30 and, perversely, their use may then increase the likelihood of erythema. A recent very large study showed that increased sunscreen use was not associated with a decrease in sunburn. 31 The SPF primarily measures protection against UVB (280-315 nm), which is much more erythemogenic than UVA (315-400 nm). 10 There is increasing recognition that protection from UVA is also important because it accounts for > 95% of terrestrial UVR. However, unlike for SPF, the definition of a UVA protection factor varies with the regulatory domain.
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Most sunscreen studies are undertaken with acute laboratory UVR exposures over small areas of skin. The aims of the current study were (i) to assess the effects of typical sunscreen use on erythema, the induction of epidermal CPDs and CHS during a 1-week holiday in Tenerife, (ii) to assess the effect on erythema after intervention with two sunscreens (with the same labelled SPF but different UVA protection factors) with instructions on how to use them to achieve the labelled SPF and (iii) to test the hypothesis that the human erythema action spectrum predicts the suppression of the sensitization phase of CHS in a laboratory study. In addition, we wanted to estimate (i) sunscreen application thicknesses in the holiday intervention study and (ii) the UVR exposure of the holidaymakers both in total and as a percentage of ambient solar erythemal exposure.
Participants and methods
The studies were undertaken according to the Declaration of Helsinki after approval from the ethics committees of the Medical University of Ł od z, Poland (holiday study) and St Thomas' Hospital, London, U.K. (laboratory study). All participants gave informed written consent.
Holiday study
The holiday location was Playa de Fanabe, Tenerife (28°08 Seventy-nine healthy volunteers, of predominantly Fitzpatrick skin types II-III (two were type IV), 33 were recruited by the dermatology department of the Medical University of Ł od z, Poland. The treatment groups and demographics are shown in Table 1 . The exclusion criteria were a history of skin disease (including skin cancer), taking photosensitizing medication, vitamin D supplements and sunbed or holiday sun exposure within the previous 4 months. The sunscreen intervention groups were termed A (n = 20) and B (n = 20). Group C (n = 22) was the discretionary sunscreen use group (i.e. typical sunscreen use) and control group D (n = 17) remained in Ł od z during the study period. The holiday groups volunteered as room-sharing pairs. Table 2 ). The SPFs were not significantly different from each other (P = 0Á7). SPFs are normally slightly higher than their labelled values to encompass the lower SD value. Figure 1 shows the sunscreens' absorption profiles and the caption provides details on their active ingredients and UVA protection factors. The codes were broken after data collection and analyses.
Volunteers from groups A and B were given three tubes daily (labelled 1, 2 and 3), which were weighed before and after use. Additional tubes (labelled 4) were available on request by men with high BSA (in practice few took this option). Each room-sharing pair was given the same product to prevent inadvertent mixing. Participants were instructed, at the start of the holiday, how to apply the sunscreen on unclothed skin to achieve the labelled SPF, and to apply tube 1 during the morning, tube 2 during the middle of the day and tube 3 during the afternoon if they intended to sunbathe or be out in the sun. They were advised to reapply after swimming or physical activity. They recorded the time of the first application for each of the tubes (on the tubes) and kept daily half-hourly accounts of their clothing cover to estimate their exposed percentage BSA 
Skin type based on the Fitzpatrick classification. 33 a Two were classified as type II/III. b Body surface area (BSA) was significantly higher in men than in women within the holiday groups (P < 0Á001) and overall (P < 0Á001). There was no significant difference (P > 0Á1) in BSA between the four study groups (for male, female or both combined).
(calculated by the Du Bois method). 34, 35 We estimated the average sunscreen application thickness (mg cm À2 ) in cases where 85% BSA (i.e. in swimwear) was exposed at the time of the first application from each tube. Participants in the discretionary sunscreen group C were advised to bring their own sunscreens as they normally would for a holiday. They were not monitored or given instructions on sunscreen use, to avoid any influence on photoprotection behaviour.
Laboratory study
Fifty-four healthy young adults of Fitzpatrick skin type I and II were recruited in London, with the same exclusion criteria as for the holiday study. Their demographic details are given in Table 3 .
Ultraviolet radiation exposure and dosimetry

Holiday study
Personal UVR exposure was monitored by means of wrist-worn SunSaver electronic dosimeters, which record time-stamped erythemal exposure expressed as the standard erythema dose (SED) per 30 min. 36 Data were downloaded on a daily basis.
Two similar devices were also placed on an unshaded location on the roof of one of the hotels to monitor ambient UVR exposure. The Ł od z control group D was given no special instructions other than to wear their SunSaver dosimeters and to ensure that they were not covered by clothing.
Laboratory study
The studies were done with three different UVR spectra; two were SSR (with different UVA : UVB ratios) and the other was pure UVA1 (340-400 nm, Sellamed 3000; Sellas, Gevelsberg, Germany). The details of the solar simulator and UVA1 source and spectroradiometric and routine dosimetry have been published previously. 37, 38 The spectral waveband details and their erythemally effective energies are given in Table 4 .
Experimental outcomes
Erythema
Quantitative measurements of redness were made on six body sites of the Tenerife participants (buttock, forehead, shoulder, chest, outer upper arm and outer lower arm) with a reflectance meter (UV Optimize Scientific 558; Chromo-Light, Espergaerde, Denmark) 39 on the day before the holiday and at The Ł od z data are based on 13 of 17 people for whom there was a full 7-day dataset with readings above the background electronic noise level. The mean Ł od z values are skewed by one outlier who spent much more time outdoors than the others. Thus, the median of the control group was 0Á76 SED exposure with 2Á1 h outdoors over the 7-day period. the end of each day during the holiday, except for the last day because of timing of the return flight. The measurements were used to generate person-and body-site-specific time courses for erythema. The area under the curve (AUC) per body site was used as an overall measure of individual cumulative erythema during the week.
Cyclobutane pyrimidine dimers
Punch biopsies (4 mm) were taken from all discretionary group C volunteers, under local anaesthesia, from the upper outer right arm, 1 day before the holiday and 24-30 h after the holiday, and were used to prepare paraffin-embedded sections. CPDs (thymine dimers, T<>T) were identified immunohistochemically and assessed as previously described. 38 The data are presented in arbitrary units.
Contact hypersensitivity
CHS is a measure of cutaneous recall immunity after skin sensitization with a hapten. The end point measured is the diameter of the circular challenge reaction, to a dose range of the same hapten.
Holiday study
The CHS protocol was based on previous experience in Poland, 40 with diphenylcyclopropenone (DPCP) sensitization on the sun-exposed upper right back 24 h after the holiday. The Ł od z control group was sensitized at the same time on the same body site. Challenge, with a range of DPCP concentrations, was done 3 weeks later on the sun-protected upper inner left arm. The CHS response was assessed 48 h later.
Laboratory study in London
The UVR dose prior to sensitization was 3 SED, on previously unexposed buttock skin (25 cm 2 ), which is approximately 1 minimal erythema dose (MED) in people of Fitzpatrick skin type I or II. 37 The positive control had no prior UVR exposure. The London protocol has been described. 41 The hapten was 2,4-dinitrochlorobenzene (DNCB). The sensitization was done 24 h after irradiations and challenge was done 3 weeks later on the upper inner arm. CHS was assessed 48 h and 72 h after challenge, with the analyses based on the time with the greatest response. The end point for analysis was the slope of the linear regression of reaction area (pr 2 ) vs. the challenge concentration of DNCB. The data are expressed as the percentage immunosuppression compared with the mean of the nonirradiated controls (normalized to 0%), as previously reported. 41 The individual control values are also given compared with their mean.
Statistical analyses
The holiday sample sizes were based on a controlled laboratory UVB intervention vitamin Bonferroni post hoc tests where necessary. Comparisons before and after the holiday within the same individuals were made by paired t-tests, and unpaired t-tests were used for comparisons between sunscreens. The significance value was set at P < 0Á05 and all tests were two-sided.
Results
Holiday study
All data were normally distributed. In total, 63% of participants were female and 37% were male, with no significant sex differences between the four study groups (P = 0Á057) or the three holiday groups (P = 0Á53). There was a just significant (P = 0Á047) Fitzpatrick skin type (II-IV) difference between the four study groups, but this significance was lost when the control group D was removed from the analysis (P = 0Á16). All outcomes were independent of sex (P = 0Á088) apart from BSA, which was significantly higher in men within the holiday groups (P < 0Á001) and overall (P < 0Á001). The sunscreen application data are shown in Figure 2 . Figure 2(a) shows the means of the three applications per person per day. The mean quantities of sunscreens A and B per application 33 Each of the UVR treatment groups was exposed to 3 standard erythemal doses. There were no differences of age (ANOVA, P = 0Á28), sex (v (based on 21 applications per person) were 37Á4 AE 6Á4 and 39Á8 AE 5Á4 g, respectively (male and female combined), and these were not significantly different (P = 0Á21). There was a consistent trend for slightly greater quantities with sunscreen B, which was probably due to this group having an overall higher BSA (Table 1 ). There was no significant difference in BSA between the four study groups (P > 0Á1, ANOVA for male, female and both combined). Figure 2 (b) shows the estimated sunscreen application thicknesses (means per person) based on participants who exposed 85% BSA at the time of the first application. These were not different between formulations (P = 0Á60). The exact values are given in Table 2 . The mean application thicknesses, always > 2Á0 mg cm À2 , were higher in women for both sunscreens, but the differences were not significant (P = 0Á20 for A and P = 0Á088 for B). However, this sex difference was borderline significant (P = 0Á050) with the sunscreens combined. The Tenerife weather was ideal for the study, with seven cloudless days. Maximum daily temperatures were around 22°C (airport). The mean ambient UVR values showed a perfect normal distribution from 07Á00 to 18Á00 h, with a mean peak of about 8 SED h À1 at the solar noon. This is equivalent to an ultraviolet index (UVI) of around 9, which is classified as very high by the World Health Organization. 43 Ambient UVR was ≥ 6 SED h À1 from 11Á30 to 14Á30 h. There was no significant difference (P = 0Á11) in the distribution of the three study groups between the two hotels, and the hotels had no impact on cumulative SED exposure (P = 0Á072). The mean cumulative SED exposures in the three holiday groups are shown in Table 2 , and were not significantly different from each other (P = 0Á08). The average cumulative exposure for all three groups was 43Á2 AE 16Á5 SED. Personal exposure was about 18-20% of ambient at solar noon. However, there was a difference in the number of hours outside (P = 0Á02), also shown in Table 2 . Post hoc multiple comparisons showed no differences between the two sunscreen intervention groups (P = 1Á0), each of which had significantly fewer hours of exposure than the discretionary-use group (P = 0Á014). The mean temperature at Ł od z airport during the study period was 5Á8 AE 4Á1°C and the maximum UVI was 2-3 (2 is low and 3 is the lowest level of moderate). 43 The control exposure data, which were correspondingly low, are shown in Table 2 . These represent 13 of 17 volunteers who had a full 7-day dataset with SunSaver readings that were distinguishable from the background electronic noise signals of the dosimeters. Examples of the holiday erythema data are shown in Figure 3 . The AUC analyses showed highly significant differences between groups A, B and C (P < 0Á001, ANOVA) for all body sites except the buttock (P = 0Á09), which was sun protected by clothing. Post hoc tests showed no erythemal differences between sunscreens A and B for any body site (P = 0Á36-1Á00). In contrast, the AUCs were very significantly higher in the discretionary-use group C than in either of the sunscreen intervention groups (P < 0Á001), except for the face, where the difference between groups A and C was still significant (P = 0Á007). Figure 4 shows a highly significant postholiday increase (P < 0Á001) of CPDs. The mean AE SD preholiday value is 31Á2 AE 21Á7 including two outliers, with postholiday values of 69Á4 AE 32Á9. The respective values, without the outliers, are 25Á7 AE 12Á5 and 64Á8 AE 30Á7 (P < 0Á001). Figure 5 shows the effect of holiday exposure on CHS. A normal positive CHS reaction was observed in 16 of 17 (94%) of the Ł od z control group. In contrast, only two of 22 (9%) of the Tenerife discretionary sunscreen use group showed a partial CHS response that was weaker than the mean control values at a given DPCP challenge concentration. Twenty of 22 (91%) of this group showed complete immunosuppression.
Laboratory contact hypersensitivity study
All data were normally distributed. There was a significant difference in immunosuppression (%) between the four groups Two UVB-UVA boundaries are given: 315 nm is the official definition but 320 nm is widely used in photodermatology. Filter 2 was COLIPA (Cosmetics Europe)-compliant solar simulated radiation (SSR), which is used for sun protection factor determination. This represents a very UVB-rich spectrum, which would be found in summer in tropical Australia (~19°S). 59 SSR filter 9 has a much lower UVB content and is more representative of winter UVR in Northern latitudes (~52°N). EEE, erythemally effective energy; CIE, Commission Internationale l' Eclairage. Note that the times for the exposures with SSR filters 2 and 9 are approximate as they varied with the irradiance on a given day (the irradiance of the UVA1 source was more stable) and that 3 SED is approximately 1 minimum erythemal dose on previously unexposed buttocks in people of skin types I/II.
(P = 0Á0034, ANOVA), which was lost for the three irradiated groups without the control (P = 0Á70). Post hoc analyses between the control group and immunosuppression in each irradiated group showed significant differences in all cases (P < 0Á005), which were maintained after Bonferroni correction (P < 0Á03). The degree of immunosuppression by 3 SED with three different emission spectra is shown in Figure 6 . As expected there was interpersonal variation in the controls.
Discussion
In the holiday group, the UVI reached a mean maximum of around 9 (classified as very high), equivalent to 8 SED h À1 , which is close to 3 MED h À1 in people of Fitzpatrick skin type II. 37 The wrist SED measurements, which are typically about 50% of those on the face, 44 were up to 20% of ambient UVR. A study in March 2010 in Tenerife 30 reported that Danes (n = 25) obtained 57Á0 AE 24Á7 SED (range 21-115) in 6 days, which was estimated to be 43% of the annual solar UVR burden of an indoor worker. This is higher than the overall mean of 43Á2 AE 16Á5 SED (range 12-93) in the current study, which had sunnier weather. The Poles acquired around 27% of their annual UVR burden, based on a Northern European indoor worker receiving a median annual exposure of about 150 SED. 45, 46 The targeted recruitment of Danish sun seekers in the 2010 study may explain their higher exposure. Danes on holiday in Egypt who applied their own sunscreens (mean labelled SPF 15) at 0Á79 mg cm À2 achieved an estimated effective SPF of around 3. 28 Compliance in the There was no difference between the application weights (P = 0Á21) of sunscreens A and B. Note that there is systematic slightly greater application of sunscreen B, possibly because this group had a slightly higher mean body surface area (BSA) (see Table 1 ). (b) Mean AE SD application thicknesses when the first application per tube was used for 85% exposed BSA, for sunscreens A and B. There was no difference between application thicknesses (P = 0Á60). The mean times of first application per tube (sunscreens A and B combined), irrespectively of percentage BSA exposed, were 09 h 28 min AE 31 min, 12 h 35 min AE 34 min and 15 h 32 min AE 33 min on days 2-7. The first applications on day 1 were at 10 h 51 min AE 45 min, 13 h 38 min AE 40 min and 16 h 42 min AE 44 min because the flight arrived in the early morning. There are data points for only 19 of 20 people for sunscreen B because one never exposed 85% BSA.
(a) (b) Fig 3 . Erythema measurements on (a) the upper outer arm and (b) the chest from the three holiday study groups (A and B, sunscreen intervention; C, discretionary sunscreen use). There was insufficient time to collect the day 7 data because of flight departure. The area under the curve for the statistical comparisons were generated from each body site for each person over 6 days. Day 0 is the preholiday value.
sunscreen intervention groups in the current study was high (Fig. 2a, b) , with sunscreens (A and B combined) applied at a mean thickness of 2Á4 AE 0Á5 mg cm À2 . These data show people can learn to use sunscreens at an application density required to achieve at least the labelled SPF. The discretionary/typical-use sunscreen group (C) was neither given instructions nor monitored on sunscreen use to minimize the so-called Hawthorne effect, in which observation influences behaviour.
There was no significant difference in the cumulative SED exposure between the three holiday groups, or between the number of hours spent outdoors in the sunscreen intervention groups. However, the discretionary-use group spent significantly (P ≤ 0Á014) more time outdoors than both sunscreen intervention groups, by approximately 1 h per day. More of this group stayed in a hotel with a west-facing terrace, which benefitted from late-afternoon sun, even though there was no significant difference in the exposure distribution of the three holiday study groups between hotels. As expected, with low ambient UVI and temperatures, the Ł od z control group had a very low level of erythemally effective UVR exposure. The observed cumulative median exposure of 0Á76 SED is equivalent to around 0Á25 MED in a person of skin type II and around 0Á2 MED in skin type III. 37 Erythema was clinically obvious in the discretionary-use sunscreen group, but not in the sunscreen intervention groups. This was supported by the quantitative AUC erythema data on five exposed body sites. There was no difference in erythema between the sunscreen intervention groups. These data show that sunscreens can prevent erythema with repeated daily-holiday high UVR exposure if applied to achieve their labelled SPF, and confirm the results from repeat SSR exposure plus sunscreen (2 mg cm
À2
) in laboratory studies. 47 The lack of difference in cumulative erythema between sunscreens A and B shows that SPF, irrespectively of UVA protection factor, is a good relative indicator of longer-term photoprotection against erythema. The intervention sunscreens were applied with an estimated mean thickness of 2Á4 AE 0Á5 mg cm À2 (groups A + B combined). Given a labelled SPF of 15, we can calculate that they reduced their SED exposures by at least 15 fold. Thus, the cumulative dose based on wrist measurements was calculated to be around 2Á7 SED (0Á4 SED per day) instead of the measured dose of around 40 SED (5Á7 SED per day). A dose of 3 SED is about 1 MED in a person of skin type I/II, 37 thus the estimated cumulative exposure in our study population (skin Holiday sun exposure significantly (P < 0Á001) increases epidermal cyclobutane pyrimidine dimers (CPDs) on the exposed outer upper arm of the Tenerife discretionary sunscreen use group C. Biopsies were taken before and after (24-30 h) the holiday. About 50% of the lesions will have been repaired by the time the postholiday biopsies were taken. Note that the two outliers with high DNA damage levels before the holiday are the same as the two who were only partially immunosuppressed (Fig. 5 ).
types II-IV) was ≤ 1 MED. This explains the lack of erythema in the sunscreen intervention groups. There was a highly significant postholiday increase in CPDs in group C (discretionary sunscreen use). We suspect that the two outliers, with high preholiday CPD values (Fig. 4) , may have violated the inclusion criteria and used a sunbed before the holiday. Nonetheless, their individual values were even higher after the holiday. The final CPD assessment reflects both its daily accumulation 47 and its relatively slow repair. We have previously reported that human epidermal thymine dimers (using antibody techniques) have a half-life of 33Á3 h after a single 2-MED (~6-SED) exposure of SSR. 48 Thus, the DNA damage immediately after the holiday in the discretionary sunscreen use group is likely to have been much higher than that observed 24-30 h later. The epidermal CPD data support an earlier study in Tenerife, 35 in which there was a highly significant UVB dose-dependent increase in thymine dimers measured in a urine assay. The T<>T dimer is the most common CPD. Cytosine-containing CPDs cause the characteristic C>T TP53 transition mutations found in most keratinocyte skin cancers, 7, 8 but the T<>T dimer is indicative of mutagenic C<>C and C<>T CPDs. There is accumulating evidence that CPDs are also important in melanoma. 9 CPDs are thought to be an important initiator of erythema based on data from an animal model 49 and humans. 10, 50 CPDs also initiate the suppression of acquired immunity in mice 16 and humans. 17 The CHS response was totally suppressed in 91% (20 of 22) of the holidaymakers. Interestingly, the two who were only partially suppressed were the outliers with high preholiday thymine dimers (Figure 4) . A normal positive CHS response was observed in 94% (16 of 17) of the Ł od z control group. The Tenerife CHS result is not surprising because a single suberythemal laboratory SSR exposure is immunosuppressive, 41 especially in people of skin type I/II, as are repeated suberythemal UVB exposures. 51 We believe that this is the first demonstration of CHS suppression under holiday conditions. The laboratory CHS studies showed that 3 SED (around 1 MED) suppressed the CHS response to the same degree (~50%), irrespectively of the UVR spectrum. UVA1 also suppresses the elicitation phase of the human CHS response, 52 with a peak at 370 nm. 12 Our data show that pure UVA1 also suppresses the sensitization phase of the CHS response. This may have implications in UVA1 phototherapy, especially with high doses. The erythema action spectrum (necessary to calculate SED exposures), which is the same as that for thymine dimers in human epidermis, 10 predicted comparable immunosuppression with three different spectra, in which case erythema may be regarded as a biomarker for the suppression of acquired immunity (CHS), as well as thymine dimer formation. The latter is also supported by an SSR study that showed that SPF (= 4) was predictive of protection from DNA damage, 53 with two sunscreens with different UVA protection factors. Furthermore, erythemally equivalent SSR doses in black and white skin result in the same levels of thymine dimers in the epidermis. 50 Thus, we may speculate that the sunscreen intervention groups were spared DNA photodamage and possibly some immunosuppression, especially as we have previously shown that sunscreens are immunoprotective in a laboratory setting. 54 We have reported that sunscreens can prevent the accumulation of thymine dimers from repeated daily suberythemal SSR exposure. 47 We have also shown that a high-SPF sunscreen can prevent DNA damage caused by acute and repeated high-dose SSR exposure. 55 However, there are very limited data on the relationship between SPF and DNA protection factor. In addition, the relationship between SPF and immune protection factor remains controversial. 56 Given the uncertainty about the relationship between SPF, DNA protection factor and immune protection factor, it is wise to advocate a 'neutral-density' approach with broad-spectrum protection. 57 An important advantage of better UVA protection may be the inhibition of oxidative damage to DNA repair proteins. 58 The strengths of the study are its execution under 'real-life' holiday conditions during a week of cloudless very sunny weather, which could not be simulated in a laboratory. Its weaknesses are that DNA damage and suppression of CHS were not measured in the sunscreen intervention groups. In Immunosuppressive effects of exposure to 3 standard erythemal doses from two different solar simulated radiation spectra (filters 2 and 9) and pure UVA1. The individual positive control results (no UVR) are expressed relative to the control mean set at 0% immunosuppression. This control mean is then used as the baseline for the individuals exposed to UVR. The UVR groups were significantly immunosuppressed compared with the controls (*P < 0Á03 with Bonferroni correction) but there was no significant difference in immunosuppression in the three UVR groups (P = 0Á70) between the three spectral groups. These data show that the erythema action spectrum is predictive of UVR-induced immunosuppression, irrespective of the emission spectrum. Comparable analyses were done without the control outlier and the outcome was essentially the same as described in the Results section. The Bonferroni adjusted P-values for UVR-induced immunosuppression compared with the controls were < 0Á036. addition, the study was done at two hotel locations. The original plan was to perform the study at a single location in Egypt, but this had to be changed at the last minute because of the Arab Spring.
In summary, discretionary (or typical for most of the general public) sunscreen use resulted in erythema, DNA photodamage and CHS suppression, which are important risk factors for skin cancer. In contrast, guided sunscreen intervention suppressed erythema. Given the similarities of the action spectra for erythema, CPDs and suppression of CHS, we may speculate that the sunscreen groups are likely to have had reduced CPDs and suppression of CHS, but this requires confirmation with additional field studies. Importantly, erythema is a biomarker of both CHS and CPDs, which supports the hypothesis that DNA is an important chromophore for immunosuppression.
Finally, this study shows that people can learn to use sunscreens with an application density that achieves the labelled SPF. However, cost was not a consideration, which in practice may influence use. Furthermore, the sunscreen packaging probably encouraged judicious use. We invite the sunscreen industry to respond to the challenge of improving sunscreen use at an affordable price.
